Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMST
8376
CALL
Defiance Daily Target 2x Short MSTR ETF
SMST
$30M
| $640K | ﹤0.01% |
6,900
-7,400
| -52% | -$412K |
|
8377
CALL
Veeco
VECO
$3.05B
| $640K | ﹤0.01% |
22,400
-6,400
| -22% | -$190K |
|
8378
CALL
Sprott Junior Gold Miners ETF
SGDJ
$267M
| $639K | ﹤0.01% |
7,600
+4,600
| +153% | +$361K |
|
8379
PUT
Jones Lang LaSalle
JLL
$16.3B
| $639K | ﹤0.01% |
1,900
-900
| -32% | -$282K |
|
8380
PUT
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
$4.9B
| $639K | ﹤0.01% |
12,100
-2,400
| -17% | -$126K |
|
8381
CALL
Qiagen
QGEN
$8.54B
| $639K | ﹤0.01% |
14,200
-3,794
| -21% | -$176K |
|
8382
CALL
Sixth Street Specialty
TSLX
$1.63B
| $639K | ﹤0.01% |
29,400
-9,600
| -25% | -$209K |
|
|
GPGI
8383
CALL
GPGI Inc
GPGI
$3.83B
| $638K | ﹤0.01% |
33,100
-10,200
| -24% | -$204K |
|
8384
PUT
Tactile Systems Technology
TCMD
$635M
| $638K | ﹤0.01% |
22,000
+6,400
| +41% | +$142K |
|
8385
CALL
American States Water
AWR
$3.36B
| $638K | ﹤0.01% |
8,800
+3,200
| +57% | +$236K |
|
8386
CALL
Pacific Biosciences
PACB
$435M
| $638K | ﹤0.01% |
341,000
+107,200
| +46% | +$206K |
|
|
BCHI
8387
GMO Beyond China ETF
BCHI
$15.1M
| $638K | ﹤0.01% |
+20,891
| New | +$626K |
|
8388
CALL
Sprott Junior Uranium Miners ETF
URNJ
$313M
| $638K | ﹤0.01% |
25,300
-4,200
| -14% | -$116K |
|
8389
Opus Small Cap Value ETF
OSCV
$708M
| $637K | ﹤0.01% |
+17,213
| New | +$645K |
|
|
TGB
8390
PUT
Trekor Metals
TGB
$2.48B
| $637K | ﹤0.01% |
112,600
-13,700
| -11% | -$64.5K |
|
8391
PUT
Seres Therapeutics
MCRB
$46.8M
| $637K | ﹤0.01% |
42,830
+18,500
| +76% | +$323K |
|
8392
PUT
Telesat
TSAT
$567M
| $637K | ﹤0.01% |
21,900
-17,900
| -45% | -$520K |
|
8393
CALL
BioCryst Pharmaceuticals
BCRX
$2.28B
| $636K | ﹤0.01% |
81,600
+52,700
| +182% | +$381K |
|
8394
PUT
Textron
TXT
$14.7B
| $636K | ﹤0.01% |
7,300
-22,700
| -76% | -$1.9M |
|
8395
CALL
Bio-Rad Laboratories Class A
BIO
$8.71B
| $636K | ﹤0.01% |
2,100
-900
| -30% | -$281K |
|
8396
VanEck Vietnam ETF
VNM
$491M
| $636K | ﹤0.01% |
33,347
-67,956
| -67% | -$1.23M |
|
8397
PUT
Rollins
ROL
$18.3B
| $636K | ﹤0.01% |
10,600
-1,300
| -11% | -$76.4K |
|
8398
State Street SPDR S&P Health Care Equipment ETF
XHE
$161M
| $636K | ﹤0.01% |
7,206
-4,690
| -39% | -$394K |
|
8399
CALL
Alto Ingredients
ALTO
$369M
| $636K | ﹤0.01% |
220,700
+146,900
| +199% | +$277K |
|
8400
PUT
Reliance Steel & Aluminium
RS
$20.7B
| $636K | ﹤0.01% |
2,200
-900
| -29% | -$253K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.